NI
70
2
PLD
32
-11
DOV
56
3
FOX
55
5
COP
50
3
KSS
26
14
USB
59
2
TMO
43
-3
BA
40
7
AIG
81
-2
GILD
64
-3
CNX
59
2
CFG
58
2
FCX
49
2
MO
68
-3
WMT
54
2
MCO
65
3
URBN
50
-2
ROK
30
2
NAVI
29
5
NI
70
2
PLD
32
-11
DOV
56
3
FOX
55
5
COP
50
3
KSS
26
14
USB
59
2
TMO
43
-3
BA
40
7
AIG
81
-2
GILD
64
-3
CNX
59
2
CFG
58
2
FCX
49
2
MO
68
-3
WMT
54
2
MCO
65
3
URBN
50
-2
ROK
30
2
NAVI
29
5
Financhill
Back

Iovance Biotherapeutics 10K Form

Sell
12

IOVA
Iovance Biotherapeutics

Last Price:
$3.53
Seasonality Move:
-6.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IOVA News And Ratings

See the #1 stock for the next 7 days that we like better than IOVA

IOVA Financial Statistics

Sales & Book Value

Annual Sales: $164.1M
Cash Flow: $-77.5M
Price / Cash Flow: 0
Annual Sales: $2.33
Price / Book: 1.64

Profitability

EPS (TTM): -1.30000
Net Income (TTM): $-372.2M
Gross Margin: $40.1M
Return on Equity: -52.91%
Return on Assets: -41.21%

Iovance Biotherapeutics Earnings Forecast

Key Iovance Biotherapeutics Financial Ratios

  • The Gross Profit Margin over the past 17 years for IOVA is 24.43%.
  • The Selling, General & Administrative Expenses for IOVA have been equal to 93.26% of Gross Profit Margin.
  • The Research & Development expenses have been 172.08% of Revenue.
  • Per Share Earnings over the last 17 years have been positive in 8 years.

Iovance Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IOVA
CUSIP: 462260
Website: iovance.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.74
Quick Ratio: 3.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IOVA Technical Analysis vs Fundamental Analysis

Sell
12
Iovance Biotherapeutics (IOVA) is a Sell

Is Iovance Biotherapeutics a Buy or a Sell?